STOCK TITAN

Vanguard realignment leads to separate reporting; 0 NEOG shares (NEOG)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group filed Amendment No. 15 to a Schedule 13G/A reporting 0 shares of Neogen Corp, representing 0% beneficial ownership. The amendment notes an internal realignment on January 12, 2026 under SEC Release No. 34-39538 that led certain Vanguard subsidiaries and business divisions to report holdings separately. The filing states those subsidiaries pursue the same investment strategies and that The Vanguard Group, Inc. no longer is deemed to beneficially own securities reported by those entities. The form lists the issuer address as 620 Lesher Place, Lansing, MI, and is signed by Ashley Grim on 03/27/2026.

Positive

  • None.

Negative

  • None.





640491106

(CUSIP Number)
03/13/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/27/2026

FAQ

Does The Vanguard Group report any beneficial ownership in NEOG?

No. The filing states 0 shares and 0% beneficial ownership. The Schedule 13G/A explains that Vanguard underwent an internal realignment on January 12, 2026, after which certain subsidiaries report holdings separately under SEC Release No. 34-39538.

What caused Vanguard to report zero NEOG ownership on the amendment?

An internal realignment is cited as the cause, per the filing. Vanguard says subsidiaries and business divisions were disaggregated after the January 12, 2026 realignment and now report beneficial ownership separately in reliance on SEC Release No. 34-39538.

Who signed the Schedule 13G/A amendment for NEOG?

The form is signed by Ashley Grim, Head of Global Fund Administration. The signature block in the filing shows the date 03/27/2026 and lists Vanguard's address at 100 Vanguard Blvd., Malvern, PA.

Do Vanguard subsidiaries still follow the same investment strategies after realignment?

Yes. The filing states the subsidiaries and business divisions "pursue the same investment strategies" as before the realignment. The Schedule 13G/A relies on SEC Release No. 34-39538 to report those entities separately.

Is any third party identified as having rights to NEOG dividends or proceeds?

No single third party is identified as holding more than 5% interest. The filing states that no other person's interest in the reported securities exceeds 5%, and lists managed accounts and investment companies as potential recipients of dividends or proceeds.
Neogen Corp

NASDAQ:NEOG

View NEOG Stock Overview

NEOG Rankings

NEOG Latest News

NEOG Latest SEC Filings

NEOG Stock Data

1.99B
215.48M
Medical Devices
In Vitro & in Vivo Diagnostic Substances
Link
United States
LANSING